Background The treatment of periprosthetic joint infection (PJI) of the shoulder with two-stage revision arthroplasty using an antibiotic-loaded cement spacer is established strategy, but there is sparse information regarding the likelihood of infection control and restoration of shoulder.
Questions/Purpose (1) What is the likelihood of infection control after two-stage revision using an antibiotic cement spacer for patients with PJI of the shoulder? (2) What are the improvements in Constant and Murley scores at 2 years after these staged revisions? Patients and Methods Between 2000 and 2013, we treated 48 patients with PJI of the shoulder using two-stage revision including an antibiotic-containing cement spacer during the first stage. Of those, 38 (79%) were available for review at a minimum of 24 months (mean, 52 6 34 months). Ten patients (21%) were excluded because they were deceased (n = 3), moved abroad (n = 4), or refused followup (n = 3), leaving 38 for analysis in this retrospective study. During the first stage, removal of the prosthesis, débridement, and implantation of a gentamicin and vancomycin-filled cement spacer were performed by four different surgeons followed by antibiotic therapy (2 weeks intravenous plus 10 weeks oral). For the second stage, we generally tried a reverse total shoulder arthroplasty (RTSA; n = 26). In case of severe glenoid destruction, hemiarthroplasty (HA; n = 8) was used as a salvage option. In 14 patients the cement spacer was left in place because the patients refused further surgery or were not operable owing to medical reasons. The primary outcome included the proportion of patients achieving infection control 2 years after the second-stage procedure after implantation of the cement spacer. Infection control was determined as the absence of the Musculoskeletal Infection Society PJI criteria. The clinical outcome assessed with the Constant and Murley scores served as the secondary outcome parameter. A subgroup (RTSA; HA, spacer retention) analysis of the Constant and Murley scores was performed. Results Successful infection control was achieved in 36 of 38 patients (95%). Patients who underwent treatment with a cement spacer had increased Constant and Murley scores at
Introduction
Periprosthetic joint infection (PJI) of the shoulder is one of the most-feared complications in orthopaedic surgery. Although the relative number of periprosthetic shoulder infections is relatively stable with approximately 1% [4] , the absolute number is increasing owing to the increasing numbers of shoulder replacements [18] .
The most-common organisms causing periprosthetic shoulder infection are coagulase-negative staphylococci and the slow-growing Propionibacterium acnes [1, 2, 23] . Propionibacterium acnes is a less-virulent organism compared with Staphylococcus aureus and coagulasenegative staphylococci, which are the main-culprit organisms in PJI of the knee and hip. Therefore the typical signs of infection frequently are missing in PJIs of the shoulder and pain is sometimes the only symptom [11] .
Owing to biofilm formation of pathogens causing periprosthetic shoulder infections, diagnosis and treatment are difficult. The use of an antibiotic-loaded cement spacer after explantation of the prosthesis in combination with a targeted antibiotic therapy followed by a secondary reimplantation is an established treatment strategy in PJIs of the knee and hip.
The same strategy has been described for periprosthetic shoulder infections [12, 20, 21, 25, 28, 29] , but there are little published data regarding infection control and functional outcome [6, 12] . Therefore, we asked: (1) What is the likelihood of infection control after two-stage revision using antibiotic cement spacers for patients with PJI of the shoulder? (2) What are the improvements in Constant and Murley scores at 2 years after these staged revisions?
Patients and Methods
The study was approved by the ethical committee of Zurich. (Cantonal Ethical Committee number: ZH-Nr.2016-01367).
Patients and Followup
All patients identified in our longitudinally maintained database who had undergone implantation of a cement spacer for an infected shoulder arthroplasty between January 2000 and December 2013 were retrospectively studied regarding control of infection and restoration of shoulder function. In the mentioned time frame, we treated 48 patients with a PJI of the shoulder using a two-stage revision approach including an antibiotic-containing cement spacer during the first stage. The reason for primary shoulder arthroplasty was posttraumatic osteoarthritis (n = 20), cuff arthropathy (n = 12), primary osteoarthritis (n = 10), and instability arthropathy (n = 6). Forty of the 48 patients had their prosthesis implanted at an external hospital and were referred to our hospital for treatment of the periprosthetic infection, and eight patients had their primary shoulder prosthesis implanted at our hospital.
During the second-step intervention 26 patients underwent reimplantation of reverse total shoulder prosthesis and eight patients had reimplantation of a shoulder hemiprosthesis. In 14 patients the intended second-stage revision was not possible.
Thirty-eight of the 48 patients (79%) were available for followup at a minimum of 24 months (mean, 52 6 34 months) and were included for functional analysis. The included 38 patients consisted of 24 men and 14 women with a mean age of 62 6 12 years (range, 32-82 years). The 10 patients (21%) who were excluded had a mean age of 70 6 9 years. Three of these 10 patients were deceased, four had moved abroad, and three had refused followup, and therefore were lost to followup before 2 years. Of the seven patients still alive, one was unreachable. The other six patients were contacted by phone and confirmed the absence of shoulder complaints or revision surgeries.
Among the 10 patients who were excluded, five underwent reimplantation of a shoulder prosthesis (three had a reverse total shoulder arthroplasty [RTSA], two had a hemiarthroplasty [HA]) during the second-stage procedure and the other five had no second-stage intervention and the cement spacer was left in place. Twelve percent of Volume 476, Number 1 Treatment of Periprosthetic Shoulder Infections With Spacerspatients were lost to followup in the RTSA group, 25% in the HA group, and 36% in the spacer group.
Indications

Infectious Disease Workup
The diagnosis of a PJI was made according to the Musculoskeletal Infection Society (MSIS) PJI criteria [22] . Control of infection was defined as absence of MSIS criteria at the latest followup. The tissue samples obtained during the second-stage surgery and the clinical and laboratory results from the latest followup after reimplantation were used to screen major and minor MSIS criteria. During implantation of the new prosthesis, at least three tissue samples were obtained. According to our microbiological culturing protocols [5] , eight different microbiological media were used. Three anaerobic Brucella agar and five aerobic agars were incubated at 37°C for at least 10 days to detect slow-growing bacteria like Propionibacterium acnes [5, 24] .
Shoulder Function
Shoulder function was assessed using the Constant and Murley score [8] , the age-and gender-matched relative Constant and Murley score [13] , and the subjective shoulder value [13] . Pain levels were assessed using the Constant and
Murley scores with values from 0 (worst pain) to 15 (no pain) points. All clinical results were assessed before cement spacer implantation and at the latest followup after the second-stage procedure. In patients who did not undergo the second-stage procedure, the clinical results from the latest followup after spacer implantation were used for functional analysis. The patient cohort was stratified in three groups depending on definitive surgical treatment. Patients who underwent reimplantation and RTSA comprised the RTSA group, those who underwent reimplantation and HA comprised the HA group. Patients in whom the cement spacer was left in place comprised the spacer group.
Treatment: Control of Infection With a Two-stage Exchange Strategy
The investigated patients were intended to be treated with a two-stage revision arthroplasty (Fig. 1) . During the first stage, the infected prostheses were removed by four different trained and experienced shoulder surgeons (KW, DCM, BJ, and CG). Tissue samples were obtained for microbiologic analysis (technique is mentioned above). After thorough débridement and irrigation, a handmade antibiotic-loaded cement spacer was implanted. A bent 3.5-dynamic compression (DC) plate (DePuy Synthes, Paoli, PA, USA) reinforced the spacer. The cement used is a high-viscosity, radiopaque, ready-to-mix bone PALACOS ® cement (Heraeus Medical GmbH, Wehrheim, Germany), which contains gentamicin (0.55 g gentamicin/45 g cement or 0.75 g gentamicin/ 60 g cement). One gram of vancomycin per 40 g cement powder was added manually during the backtable preparation of the handmade spacer. The postoperative antibiotic therapy, according to the local protocol [30] , consisted of 2 weeks of intravenous antibiotic therapy, starting with empiric intravenous antibiotic therapy with intravenous amoxicillin plus clavulanic acid followed by targeted intravenous antibiotic therapy, as soon as the bacterial pathogen was identified. After 2 weeks of intravenous antibiotic therapy, oral therapy was administered for a mean of 10 6 4 weeks. The antibiotic therapy was determined together with consultants from the infectious disease service from the local university. In the absence of major and minor MSIS PJI criteria, the second-stage was performed after a mean of 7 6 9 months by the four different shoulder surgeons. For the second stage, we generally tried, when possible, reimplantation of a reverse total shoulder prosthesis (Fig. 2) . In case of severe glenoid destruction, a shoulder hemiprosthesis served as a salvage option. In 14 patients the cement spacer was left in place because they refused further surgery or were not operable owing to medical reasons.
Statistical Analysis
Study data were collected and managed using REDCap ® (Version 6.7.4; Vanderbilt University, Nashville, TN, USA; https://www.project-redcap.org/) [17] . Statistical analysis was performed using SPSS Version 23.0 (IBM Corporation, Armonk, NY, USA). Differences between group means preand postoperatively were investigated using paired t-tests.
Before statistical comparison of group means the samples were tested for homogeneity of variance using Levene's test, and where appropriate Welch correction was applied. Significance was set at a = 0.05.
Results
Infection Control
Infection control was successful in 36 of 38 patients (95%); two had positive intraoperative cultures, persistent pain, and showed radiologic signs of a persistent infection. The first patient with absence of infection control was a 72-year-old woman with P acnes growth in three of four specimens after reimplantation of the shoulder hemiprosthesis. The patient underwent an additional course of targeted antibiotic therapy for 3 months after reimplantation. A risk factor was the corticosteroid therapy, attributable to ulcerative colitis. At the last followup the patient had shoulder pain without any systemic infection signs. The second patient with a relapse of infection was a 57-year-old man with growth of coagulase-negative staphylococcus in four of five tissue samples which were taken during the reimplantation and RTSA. Targeted antibiotic treatment was administered for 3 months. This patient had no known risk factors. Both patients refused further surgical interventions and tolerated the painful shoulder.
Functional Outcome
Patients who underwent treatment with antibioticcontaining spacers (regardless whether the spacer was 
Other Findings
Complications Twenty-eight complications (48 patients [58%]) were identified with review of the patients' medical history. In 18 of the 48 patients (35%), revision surgery was performed. The most-common complications were glenoid destruction after spacer implantation (n = 6), postoperative hematoma (n = 5), instability (n = 3), wound healing problems (n = 2), aseptic glenoid loosening (n = 2), periprosthetic fracture (n = 2), and persistent infection (n = 2). After RTSA, 14 complications occurred, and 10 revision surgeries were performed. After HA, 10 complications were registered and five revision surgeries were performed. In the spacer group two complications and two revision surgeries were noted. The most-common cause for revision surgery was postoperative hematoma (n = 5).
Pathogens
The most-common isolated pathogens isolated during implantation of the cement spacers were coagulase-negative staphylococci in 42% (20 patients) followed by P acnes in 33% (16 patients). Three patients had a polymicrobial infection with two or more isolated microorganisms. In five patients in whom we suspected a shoulder PJI, no organism was detectable in any intraoperative specimen or aspiration culture.
Discussion
For low-grade periprosthetic shoulder infections, twostage revision arthroplasty using an antibiotic-loaded cement spacer is a common treatment strategy. Published studies regarding the likelihood of infection control of a two-stage revision approach using an antibiotic-loaded cement spacer provide litte data [6, 12] .
Therefore, we aimed to analyze the rate of infection control and evaluate functional outcome improvement in patients who underwent implantation of an antibioticloaded cement spacer for an infected shoulder prosthesis between January 2000 and December 2013.
The study has three major limitations. First, the different subgroups are too different in their baseline characteristics, so comparison of the functional results should not be done. Severe glenoid destruction was the main reason why patients underwent secondary HA and not the intended RTSA during the second-stage intervention. This selection bias is the reason why it is very likely that these mentioned baseline differences influenced the functional outcome more than the selection of the definitive implant. Furthermore, the subgroups were too small (n = 6 and n = 9) to allow any conclusions regarding functional outcomes. Further studies in a prospective setting with higher subgroup numbers and with clear and consistent indications are necessary to make a meaningful statistical comparison possible between the different implants in patients with PJI of the shoulder. Second, 10 patients were lost to followup (21%). Of those three had died, and another was unreachable. The other six patients were contacted and we could confirm the absence of shoulder complaints in five of those six patients.
The third limitation is the retrospective study design. However, patients' data were longitudinally maintained in a database and systematically followed by Constant and Murley scores and standardized radiographs before surgery and at regular followups after the index surgery. With that, a transfer bias of patients can be excluded.
Treatment of periprosthetic shoulder infections using an attempted two-stage revision with an antibiotic-containing cement spacer resulted in infection control in nearly all (95%, 36 of 38) patients in this small series. This is comparable to the 91% infection control rate reported in a systematic review of 13 studies with 142 patients who underwent two-stage arthroplasty exchange [12] . Nevertheless, the additional expense of a two-stage revision was invested to achieve this high level of infection control. However, if the infection control of our cohort is compared with those of single-stage exchange studies, the success rates seems comparable [3, 12] , which would tend to favor a single-stage strategy with less morbidity and comparable infection control rates even for patients in whom the bacteria is unknown [3, 16] .
Patients who underwent treatment with antibioticcontaining spacers had increased Constant and Murley scores, relative Constant and Murley scores, subjective shoulder values, and pain scores at latest followup compared with their pretreatment scores. If the glenoid bone stock was sufficient and the implantation of a reverse shoulder prosthesis was possible, the shoulder function improved. If the glenoid destruction was severe, a shoulder hemiprosthesis served as the salvage option. Therefore, it is very likely that the posttreatment functional results depended more on the glenoid bone condition than on implant selection.
The clinical and subjective results seem inferior to published results obtained after primary RTSA for cuff arthropathy [27] , complex humerus fractures [10, 14, 26] , or secondary RTSA after failed osteosynthesis of a proximal humerus [15] . Our functional outcome data with a mean Constant and Murley score of 51 points (range, 14-78 points) for the RTSA group is comparable to those of earlier studies of single-stage [3, 9, 19] and two-stage arthroplasty exchange [6, 7, 9, 12, 17, 25, 29] , with or without an antibiotic spacer. However, these studies did not evaluate the functional outcome of patients with definitive cement spacers. One study with nine patients who were [21] . Revision arthroplasty using an antibiotic-loaded cement spacer provides successful infection control in patients with periprosthetic shoulder infections in this small, retrospective series. Restoration of shoulder function will most likely be acceptable if a RTSA can be performed after the cement spacer treatment. However, the risk of complications and revision appears very high. Future studies with more-consistent indications are needed to make comparison of functional outcomes depending on implant selection possible.
